bf/NASDAQ:GILD_icon.png

NASDAQ:GILD

Gilead Sciences, Inc.

  • Stock

USD

Last Close

68.49

21/06 20:00

Market Cap

99.09B

Beta: 0.40

Volume Today

29.62M

Avg: 5.58M

PE Ratio

16.30

PFCF: 11.99

Dividend Yield

3.91%

Payout:48.14%

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, ...Show More

Earnings

Earnings per Share (Estimate*)

0.511.522.533.52015-07-282017-07-262019-07-302021-07-292023-08-03

Revenue (Estimate*)

2B4B6B8B2015-07-282017-07-262019-07-302021-07-292023-08-03

*Estimate based on analyst consensus